{"id":55105,"date":"2016-11-01T16:28:50","date_gmt":"2016-11-01T20:28:50","guid":{"rendered":"https:\/\/www.nationaldrugscreening.com\/?p=55105"},"modified":"2022-12-01T11:21:47","modified_gmt":"2022-12-01T16:21:47","slug":"dot-eccf-electronic-chain-of-custody-for-dot-drug-testing","status":"publish","type":"post","link":"https:\/\/www.nationaldrugscreening.com\/blogs\/dot-eccf-electronic-chain-of-custody-for-dot-drug-testing\/","title":{"rendered":"DOT ECCF \u2013 Electronic Chain of Custody for DOT Drug Testing"},"content":{"rendered":"\n<p>\u2026Paperless Drug Testing<\/p>\n\n\n\n<p>ECCF for DOT drug testing is available and very active among collection sites and laboratories.  Software programs that provide electronic specimen collections include Escreen 123 and FormFox.&nbsp;<\/p>\n\n\n\n<p>All major SAMHSA certified are not offering ECCF or electroinic collections including: Alere Toxicology Services, Clinical Reference Laboratory, Quest Diagnostics and Labcorp.<\/p>\n\n\n\n<p>FormFox which is a web based application to process eCCF for DOT is aggressively training collection sites for the use of its application on eCCF for DOT.&nbsp; FormFox will initially be working with Clinical Reference Labs and Quest Diagnostics for collections using eCCF for DOT.&nbsp; FormFox is a web-based software application utilized by drug testing collection sites and on-site collectors for managing the specimen collection process and associated record keeping, administrative and management tasks.<\/p>\n\n\n\n<p>National Drug Screening (NDS) offers the ability to order <a href=\"https:\/\/www.nationaldrugscreening.com\/dot-drug-test\/\"><strong>DOT drug screens electronically<\/strong><\/a> processing specimens through Quest Diagnostics and LabCorp. NDS is also connected with Alere Toxicology for eCCF for DOT at the eScreen network of collection sites. NDS clients using Clinical Reference Labs (CRL) can order electronic drug tests with the FormFox order software. <\/p>\n\n\n\n<p>NDS users who are specimen collectors will also be able to process eCCF DOT collection using our software platform for DOT tests going to Quest and to Clinical Reference Laboratories (CRL).<\/p>\n\n\n\n<p>ECCF is a reality.&nbsp; Training is necessary for all users and systems.  ECCF is a way to streamline the drug testing process with more efficiency, no paper and less errors. <\/p>\n\n\n\n<p>Learn More: <a href=\"https:\/\/www.nationaldrugscreening.com\/dot-eccf\/\" data-type=\"URL\" data-id=\"https:\/\/www.nationaldrugscreening.com\/dot-eccf\/\">ECCF Paperless Drug Testing Available<\/a><\/p>\n\n\n\n<p><\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u2026Paperless Drug Testing ECCF for DOT drug testing is available and very active among collection sites and laboratories. Software programs that provide electronic specimen collections include Escreen 123 and FormFox.&nbsp; All major SAMHSA certified are not offering ECCF or electroinic collections including: Alere Toxicology Services, Clinical Reference Laboratory, Quest Diagnostics and Labcorp. FormFox which is [&hellip;]<\/p>\n","protected":false},"author":12,"featured_media":952,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_seopress_robots_primary_cat":"none","_relevanssi_hide_post":"","_relevanssi_hide_content":"","_relevanssi_pin_for_all":"","_relevanssi_pin_keywords":"","_relevanssi_unpin_keywords":"","_relevanssi_related_keywords":"","_relevanssi_related_include_ids":"","_relevanssi_related_exclude_ids":"","_relevanssi_related_no_append":"","_relevanssi_related_not_related":"","_relevanssi_related_posts":"51212,51541,50975,51209,51071,50905","_relevanssi_noindex_reason":"","footnotes":""},"categories":[1],"tags":[],"acf":[],"_links":{"self":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/55105"}],"collection":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/users\/12"}],"replies":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/comments?post=55105"}],"version-history":[{"count":0,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/posts\/55105\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media\/952"}],"wp:attachment":[{"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/media?parent=55105"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/categories?post=55105"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.nationaldrugscreening.com\/wp-json\/wp\/v2\/tags?post=55105"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}